| Database ID | Agent | Target | Cancer Type | Detail |
| DB00301 | regorafenib | Protooncogene tyrosineprotein kinase receptor ret
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Vascular endothelial growth factor receptor 3 | colorectal cancer | view |
| DB00302 | linifanib | Macrophage colonystimulating factor 1 | colorectal cancer | view |
| DB00303 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00304 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00305 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00306 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | colorectal cancer | view |
| DB00307 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | colorectal cancer | view |
| DB00308 | cetuximab | Epidermal growth factor receptor | biliary tract and gallbladder cancer | view |
| DB00309 | bevacizumab | Vascular endothelial growth factor | colorectal cancer | view |
| DB00310 | BAY 869766 | Dual specificity mitogenactivated protein kinase kinase | advanced solid tumors | view |
| DB00311 | PHA848125AC | dual tropomyosin receptor kinase A and cyclindependent kinase | advanced solid tumors | view |
| DB00312 | erlotinib | Epidermal growth factor receptor | advanced solid tumors | view |
| DB00313 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00314 | Cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00315 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |